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Abstract
The oxygen dependence of a first generation amperometric biosensor was investigated in vitro and in vivo by monitoring its
glucose response as a function of solution pO2. The biosensor was a glucose oxidase (GOx) modified poly(o -phenylenediamine)
coated Pt cylinder electrode (Pt/PPD/GOx) that has been designed for neurochemical analysis in vivo. Two types of oxygen probes
were used: a self-calibrating commercial macroelectrode in vitro; and a carbon paste microelectrode in vivo. Calibrations in vitro
showed that oxygen interference in the operation of Pt/PPD/GOx electrodes was minimal for concentrations of glucose (/0.5 mM)
and oxygen (/50 mM) found in brain ECF. This observation was confirmed by simultaneous monitoring in vivo of brain glucose
and oxygen in the awake rat. However, at levels of glucose normally found in peripheral tissues (/5 mM), the oxygen dependence
was severe. We conclude that the oxygen sensitivity of Pt/PPD/GOx biosensors does not preclude their reliable use in media
containing low glucose levels, such as brain ECF. # 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The incorporation of biologically active molecules
into sensing devices has promoted considerable devel-
opment of fast, efficient and inexpensive assays for a
wide range of analytes in research, clinical, industrial
and environmental applications (Braguglia, 1998; Zhang
et al., 2000; Karube and Nomura, 2000; Liang et al.,
2000; Wang, 2001). In particular, the immobilization of
enzymes onto electrode surfaces provides biosensors
that can be categorized broadly as first, second or third
generation devices depending on the mode of electron
transfer between the redox center of the enzyme and the
electrode surface (Wang, 1993; Scheller et al., 1993).
Using the flavoenzyme glucose oxidase (GOx), the
majority of these sensors have focused on the ampero-
metric detection of glucose, both as a model system and
because of the importance of glucose as a target analyte
(Magner, 1998).
The overall enzymatic process, that is similar for
many oxidases, may be written as Eq. (1) and Eq. (2):
b-D-glucoseGOx=FAD0D-glucono-d-lactone
GOx=FADH2 (1)
GOx=FADH2O20 GOx=FADH2O2 (2)
H2O20 O22H
2e (3)
where FAD is the oxidised form of the prosthetic group,
flavin adenine dinucleotide. Eq. (3) represents the
electrochemical step, generating current, and is generally
carried out amperometrically at relatively high applied
potentials. A clear limitation of this reaction scheme (1/
3) from an analytical perspective, is that the signal (Eq.
(3)) may be prone to interference by the effect of changes
in pO2 in Eq. (2), undermining its use to reflect glucose
concentrations unambiguously. Indeed, in some situa-
tions, such as bioprocess monitoring and in vivo
measurements, O2 availability may be very limited.
Attempts to overcome this problem include the use of
membranes (Sakamoto, 1992) and different electrode
geometries (Lucisano and Gough, 1988; Pishko et al.,
1991), and while many of these modifications have
helped alleviate the oxygen problem, they have not
succeeded in eliminating it.
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Classical, or first generation, devices involve monitor-
ing either the consumption of O2 (Clark and Lyons,
1962) or the formation of H2O2 (Updike and Hicks,
1967) by the oxidase. The latter remains the most
common form of biosensor despite requiring a large
overpotential at which reducing agents present in the
sample can contribute to the faradaic current. Although
some of the problems associated with anodic H2O2
detection have been minimized by using electrocatalytic
H2O2 reduction at low potentials (Gao et al., 1992;
Vreeke et al., 1992; Wang et al., 1994, 1996),
the question of sensitivity to pO2 appears in an
additional form*/the possibility of direct faradaic
reduction of O2.
As an alternative approach, there has been an upsurge
in the development of second generation systems in
which O2 is replaced with an artificial mediator. Many
such redox mediators have been used successfully,
including metallocenes, quinones, ferrocyanide and
tetrathiafulvalene (Di Gleria et al., 1986; Wang, 1993).
The advantages of such devices are that the electrode
may be operated at lower applied anodic potentials, and
since molecular oxygen is not the final electron acceptor,
these sensors might be expected to be relatively inde-
pendent of changes in pO2. There are reports, however,
where artificial mediators could not compete effectively
with O2 (Razumas et al., 1993; Wilke and Muller, 1994;
Martens and Hall, 1994), and the continuous leaching of
potentially toxic mediator is an inherent problem for
applications in vivo.
A number of laboratories have described the devel-
opment and characterization of a first generation
glucose sensor based on a GOx-modified poly(o -pheny-
lenediamine) coated Pt (Pt/PPD/GOx) electrode that
possesses a variety of properties indicating suitability for
neurochemical applications (Sasso et al., 1990; Malitesta
et al., 1990; Reynolds and Yacynych, 1993; Bartlett and
Birkin, 1994; Lowry et al., 1994a). These attributes
include fast response time, linearity over the relevant
concentration range, effective elimination of interference
by endogenous reducing agents such as ascorbic acid,
freedom from protein and lipid fouling, stability in vivo,
and ease of miniaturisation (O’Neill and Lowry, 2000).
In a preliminary publication, we demonstrated that Pt/
PPD/GOx sensors might also be free of O2 interference
in applications both in vitro and in vivo by showing that
they responded to glucose with similar sensitivity over a
wide range of pO2 values in vitro (Lowry et al., 1994b).
As this phenomenon has important implications both
for the development of biosensors and for their opera-
tion in biological systems, where O2 availability is
restricted, we examine it now in more detail. A
preliminary report of some of these findings has been
published (Dixon et al., 2001).
2. Materials and methods
2.1. Chemicals and solutions
The enzymes GOx from Aspergillus niger (EC 1.1.3.4,
type VII-S), Ketamine and acetazolamide (Diamox)
were obtained from Sigma Chemical Co. o -Phenylene-
diamine (o-PD) (1,2-diaminobenzene, Sigma), a-D-(/)-
glucose (Sigma), L-ascorbic acid (AA, BDH Biochemical
grade), and bovine serum albumin (BSA, Armour
Pharmaceutical Co. Ltd, fraction V from bovine
plasma) were used as supplied. Carbon paste was
prepared by thoroughly mixing 2.83 g carbon powder
(UCP-1-M, Ultra Carbon Corporation, Bay City, MI)
and 1.0 ml silicone oil (Aldrich, Cat. No. 17 563-3).
A stock 1 M solution of glucose was prepared in
water, left for 24 h at room temperature to allow
equilibration of the anomers, and then stored at 4 8C.
All experiments in vitro were carried out in a phosphate
buffered saline (PBS) solution, pH 7.4; NaCl (Merck,
BP USP grade, 150 mM), NaH2PO4 (BDH, AnalaR
grade, 40 mM) and NaOH (BDH, GPR grade, 40 mM).
A 200 U/ml solution of GOx was prepared by dissolving
15 mg in 10 ml of PBS. The 300 mM o -PD monomer
solution was prepared using 0.32 g of o-PD and 50 mg
of BSA in 10 ml of PBS and sonicating at 25 8C for 30
min.
2.2. Instrumentation and software
Experiments were microcomputer controlled with
data collection accomplished using either a Biodata
Microlink interface or a National Instruments (NI,
Austin, TX) AT-MIO-16 data acquisition board linked
to a low-noise, low-damping potentiostat (Biostat II,
Electrochemical and Medical Systems, Newbury, UK).
The 2-channel configuration of the potentiostat allowed
different potential waveforms to be applied to two
working electrodes simultaneously. In-house software
was written in QuickBASIC (version 4.0) and NI
LabWindows (version 2.1) QuickBASIC environments
to perform all amperometric experiments and to collect,
plot, and do a preliminary analysis of the data.
2.3. Working electrode preparation
The fabrication of the working electrode biosensors
has been described in detail recently (O’Neill et al., 1998;
Lowry et al., 1998b). Briefly, cylinders (/1 mm long) of
freshly cut Teflon-insulated Pt wire (60 mm radius) were
dipped into a 200 U/ml solution of GOx to allow
adsorption of the enzyme, and then removed to dry. The
enzyme-coated wire was then immersed into PBS con-
taining the monomer and BSA, and electropolymerisa-
tion carried out at 700 mV vs. saturated calomel
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electrode (SCE) for 15 min to produce Pt/PPD/GOx
sensors.
The carbon paste electrodes (CPEs) for the detection
of solution O2 in vivo were made from Teflon-coated
silver wire (200 mm internal diameter, 280 mm external
diameter). The Teflon insulation was slid along the wire
to create an approximately 1-mm deep cavity that was
packed with carbon paste using a bare silver wire as
plunger. When not in use all electrodes were stored in
PBS at 4 8C.
A self-calibrating commercial membrane-covered am-
perometric oxygen sensor (/1 cm diameter) was used
to quantify solution oxygen concentration in vitro. The
model used was a CellOx 325 connected to an Oxi 340A
meter (Wissenschaftlich-Technische Werksta¨tten GmbH
from Carl Stuart Ltd, Dublin, Ireland), incorporating a
temperature probe for automatic compensation. Reli-
able quantification of O2 using this device required
constant stirring of the solution at a rate of /2 Hz. The
sensor range was 0.0/199.9% O2 (100% corresponding
to air saturation) with a resolution of 0.1%. For some
purposes, this percentage was converted to an estimated
concentration of O2, taking 200 mM to correspond to
100% (Bourdillon et al., 1982; Zhang and Wilson, 1993).
2.4. Amperometric experiments in vitro
All experiments in vitro were performed in a standard
three-electrode glass electrochemical cell containing 20
ml PBS thermostated at 25.09/0.5 8C. A SCE was used
as the reference electrode, and a large silver wire,
isolated in a compartment containing PBS, served as
the auxiliary electrode. The applied potential for am-
perometric studies was /700 mV vs. SCE unless stated
otherwise, which is the value generally used for H2O2
detection. To avoid contamination by oxygen, the
electrochemical cell was contained within an Atmos-
bagTM (Sigma), a two-hand 0.003-in. gauge polyethy-
lene bag that was sealed and filled with N2 during
experiments, inflating to a volume of 280 l.
The addition of glucose was not carried out until the
electrodes were well settled giving a steady background
in air-saturated PBS. After the addition of a single
aliquot of glucose, the bag was sealed and high-grade N2
(B/5 ppm O2) introduced. The time required to achieve
minimal O2 concentrations in solution (B/1 mM) was
approximately 3 h (Fig. 1A), even at a driving pressure
of 1 kg/cm2 and an open nipple valve on the N2 cylinder.
Oxygen sensor data and biosensor data were recorded
simultaneously through the transition from air satura-
tion to N2 saturation and/or vice versa, the biosensor
data normalized relative to the respective air saturation
value, and plotted against the measured concentration
of O2.
To calibrate the CPEs used for oxygen detection in
vivo, differential pulse amperometry (DPA, one pulse
pair:/150 to/350 mV and/350 to/550 mV from a
resting potential of /150 mV) was used in vitro as
described recently (Lowry et al., 1996, 1997). The CPEs
were calibrated after removal from the brain because
implantation affects the sensitivity of these paste elec-
trodes (O’Neill, 1993; Kane et al., 1998). Residual DPA
current recorded in N2-saturated PBS, due to uncom-
pensated capacitance and surface redox processes, was
subtracted from the current recorded in air-saturated
(200 mM) and O2-saturated (1.26 mM) buffer (Bourdil-
lon et al., 1982; Zhang and Wilson, 1993).
Non-linear regression analysis of the oxygen depen-
dence of the glucose signal was carried out using a
software package (Prism, GraphPad Software, Inc., San
Diego, CA) and a Michaelis/Menten type equation (Eq.
(4), where i is the biosensor signal). The reactant, sub, is
usually the enzyme substrate (glucose, Eq. (1)) or, as in
this study, the co-substrate (dioxygen, Eq. (2)) whose
concentration is being varied, and Km is an apparent
Michaelis/Menten constant. When sub is the target
Fig. 1. (A) Example of raw data for oxygen (CellOx sensor, black,
right axis) and glucose (Pt/PPD/GOx biosensor, grey, left axis)
recorded in vitro. 0.5 mM glucose was injected into PBS, containing
ambient levels of air, at the first arrow. Nitrogen was then introduced
(second arrow) into the AtmosBag surrounding the electrochemical
cell. Removal of O2 followed a one-phase exponential decay with a
half-life of 359/5 min (n/4). (B) Glucose/oxygen correlation plot for
data shown in A above. Non-linear regression using Eq. (4), gave
Km(O2)/159/1 mM and imax/1.09/0.1 nA, with R2/0.996.
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analyte, a large value of Km is beneficial (i is then linear
in [sub]). However, when sub is a possible interference
species, a small value of Km is advantageous because i is
then independent of [sub] except at very low [sub]
values; Fig. 1B.
i
imax
1
Km;sub
[sub]
(4)
2.5. Experiments in vivo
Male Sprague/Dawley rats weighing 200/300 g were
anaesthetised and implanted with two electrochemical
sensors as described previously (Lowry and Fillenz,
1997). The Pt/PPD/GOx electrode was implanted in the
right striatum at co-ordinates (skull levelled between
bregma and lambda): A/P/1.0 from bregma, M/L/2.5,
and D/V/5.0 (from dura). A CPE was implanted in the
left striatum at corresponding co-ordinates. The refer-
ence electrode (8T silver wire, 200-mm bare diameter)
was placed in the cortex, the auxiliary electrode (8T
silver wire) placed between the skull and dura, and an
earth wire (8T silver wire) attached to one of the support
screws. The electrodes were attached to a socket, and
fixed to the skull with screws and dental acrylate.
Animals were allowed 24 h to recover after surgery.
All procedures were specifically licensed under the
Animals (Scientific Procedures) Act, 1986 (UK) and
involved simultaneous monitoring of O2 using DPA
with the CPE (Lowry et al., 1996, 1997) and of glucose
using amperometry with the Pt/PPD/GOx sensor held at
/700 mV (Lowry et al., 1994a, 1998b).
All data are reported as mean9/SEM with n/
number of electrodes. The statistical significance of all
drug effects was estimated using Student’s two-tailed
paired t-tests on the absolute currents.
3. Results and discussion
3.1. Oxygen detection in vitro
A recent report on the oxygen dependence of Pt/PPD/
GOx biosensors (Wang and Lu, 1998) prompted us to
re-appraise our previous conclusion, based on a pre-
liminary pilot study (Lowry et al., 1994b), that these
devises were essentially free of oxygen interference at
physiologically relevant levels of O2. The more rigorous
quantification of solution oxygen achieved here, using
the self-calibrating CellOx 325 electrode, showed that in
our previous experimental design (cell open to the
atmosphere), the solution oxygen concentration did
not fall below 369/5 mM (n/5), even after extensive
bubbling of the PBS with nitrogen, and explains the
discrepancies between the two reports. To confirm the
ability of the commercial O2 sensor/meter system to
quantify zero pO2 levels, 1 mM of the O2-scavenger,
sodium dithionite, was added to the N2-challenged PBS.
When the dithionite was added, the reading dropped to
a value not significantly greater than zero (/0.5 mM
O2).
To avoid this oxygen contamination, an AtmosBag
was used to isolate the cell from the atmosphere in all
subsequent experiments in vitro, and nitrogen gas
introduced directly into the bag (not bubbled through
the solution) to avoid turbulent convection. Fig. 1A
shows the time course for removal of oxygen from the
PBS and the effectiveness of the bag in preventing
oxygen contamination in the cell. Removal of O2 had a
half-life of 359/5 min (n/4) and sub-micromolar levels
of O2 could be achieved after /3/4 h of flushing with
nitrogen.
3.2. Oxygen-sensitivity of Pt/PPD/GOx responses to
glucose in vitro
The glucose calibration profile and sensitivity of this
type of enzyme/polymer-based sensor have been re-
ported extensively (Sasso et al., 1990; Malitesta et al.,
1990; Reynolds and Yacynych, 1993; Bartlett and
Birkin, 1994; Lowry et al., 1994a). Because stirring
was necessary in the present experiments to allow the
CellOx O2 probe to function quantitatively, and because
convection affects the glucose current (Bartlett and
Whitaker, 1987), the absolute size of the glucose signal
is neither comparable to previous studies nor of much
relevance. The focus here is the effect of oxygen on the
glucose response, and so a normalized current was
calculated, using the air-saturated current for each
glucose concentration as 100%.
Fig. 1A shows an example of the absolute current
response of a Pt/PPD/GOx electrode to 0.5 mM glucose
in air-saturated stirred PBS. When oxygen was then
removed from the solution, both the O2 and biosensor
signals decreased, albeit with different time courses, and
approached zero as oxygen was completely removed
from the system, as expected from Eqs. (2) and (3). Fig.
1B shows the glucose/O2 correlation plot constructed
from the raw data in Fig. 1A; the plot was hyperbolic
(Eq. (4)) with Km(O2)/159/1 mM and R2/0.996. The
0.5 M glucose current, therefore, was effectively insensi-
tive to changes in O2 levels above /40 mM O2, but the
sensitivity to O2 increased below this level.
The turnover of O2 in the polymer/enzyme composite
membrane (Eq. (2)) depends on the rate at which
glucose binds to the enzyme (Eq. (1)), i.e., on the
concentration of glucose. We therefore carried out
experiments similar to those in Fig. 1A over a range of
glucose concentrations (0.5, 1.0, 2.5, 5.0, 7.5 and 10.0
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mM), and analysed the results as in Fig. 1B. For clarity,
Fig. 2 shows only the glucose/O2 correlation plots of
averaged normalized data for 0.5, 2.5 and 10.0 mM
glucose. As predicted, the O2 dependence became more
acute at higher glucose concentrations. For 10 mM
glucose, a level not much greater than the normogly-
cemic value in human blood (Eyre et al., 1994) and less
than that observed under hyperglycemic diabetic condi-
tions (Hofer and Lanier, 1991), the O2 dependence was
close to maximal with a Km(O2)/1739/47 mM (n/6).
The Pt/PPD/GOx sensor design would therefore not be
suitable for monitoring blood glucose in vivo. Although
the trend in Km(O2) from 0 to 10 mM glucose shown in
Fig. 3A demonstrates a high O2 sensitivity even at
moderate glucose levels, the question remained whether
Pt/PPD/GOx electrodes might be suitable for monitor-
ing brain glucose, where the estimated level is much
lower than in blood. ECF glucose in rat striatum has
been determined by both quantitative microdialysis:
3509/20 mM (Fray et al., 1997), 3509/16 mM (Lowry
et al., 1998a) and 710 mM (McNay et al., 2001) and
biosensor data: 300/400 mM (Lowry and Fillenz, 2001)
in the awake rat.
Although O2 ECF levels farthest from blood brain
capillaries can be as low as 5 mM (Siesjo, 1978),
electrodes the size of CPEs and Pt/PPD/GOx sensors
sample the average tissue ECF concentration, estimated
at /50 mM (Nair et al., 1987; Murr et al., 1994). We
therefore calculated the percentage O2 interference in
the glucose signals at 50 mM O2 per micromolar change
in O2 concentration (S%), i.e., the tangential slope of
plots similar to those in Fig. 1B determined at 50 mM
O2. The results of this analysis are shown in Fig. 3B. The
data points were consistent with both linear (not shown)
and hyperbolic fits that were distinguished only by their
behaviour as the concentration of glucose approached
zero. Unfortunately, because of the stirring needed for
the determination of O2 and the long time needed to
remove O2 from the system (/3 h, Fig. 1), sufficiently
stable glucose signals for concentrations below 0.5 mM
were not achievable in vitro. However, one can argue
that as the concentration of glucose, and therefore the
turnover of enzyme (Eq. (1)), approach zero, the Pt/
PPD/GOx signal would be the same for 49 and 51 mM
O2; i.e., S% should also approach zero. Therefore the
hyperbolic fit is the better one, a conclusion supported
by the finding that Km(O2) approaches zero under these
conditions (Fig. 3A). Using this fit, the extrapolated
value of S% for 350 mM glucose was calculated as 0.14%
per mM O2. This suggests that increases in brain pO2
would have negligible impact (B/0.14% per mM O2) on
the glucose signal recorded in brain ECF and that
decreases in pO2 would only be significant if the tissue
O2 levels became severely depleted. The non-linearity of
these functions, however, preclude the use of a single
number to define the interference of O2 in measuring
Fig. 2. Examples of averaged normalized glucose/oxygen correlation
plots (Fig. 1) for three of the six concentrations of glucose studied over
the relevant range of O2 concentration (N2 saturation to air saturation)
showing the increased sensitivity of the biosensor signal to solution
pO2 as the concentration of glucose was increased. Non-linear
regression plots shown were obtained using Eq. (4). Averaged Km
values for the individual plots are presented in Fig. 3.
Fig. 3. (A) A plot of the average Km(O2) values vs. glucose
concentration, obtained using Eq. (4) and glucose/oxygen correlation
data similar to that shown in Fig. 1B, and linear regression analysis
(R2/0.96), showing the increased sensitivity of the biosensor signal to
solution pO2 as the concentration of glucose was increased. (B) The
average percentage O2 interference in the glucose signals at 50 mM O2
per micromolar change in O2 concentration (S%), obtained by
averaging the tangential slopes (at 50 mM O2) of plots similar to those
in Fig. 1B. An hyperbolic curve was fitted to allow S% to approach
zero as the concentration of glucose approaches zero (see text for
discussion).
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glucose, and so this conclusion was tested by monitoring
the Pt/PPD/GOx glucose signal in brain ECF and
manipulation brain pO2.
3.3. Oxygen-sensitivity of Pt/PPD/GOx responses to
glucose in vivo
The carbonic anhydrase inhibitor acetazolamide (Dia-
mox) administered systemically has been shown to
increase pO2 in brain ECF (Clark and Lyons, 1965).
Fig. 4 shows the effect of this drug (50 mg/kg, i.p.) on
the glucose and O2 signals recorded simultaneously in
rat striatum. As expected, Diamox increased O2 levels in
the ECF. Calibration of the CPEs recovered after the
experiments allowed us to estimate this increase as 409/
12 mM (n/5, PB/0.03) 10 min after the injection, which
is similar to the increase observed following mild stress
(Lowry et al., 1996). There was no corresponding
change in the glucose signal at this time: 9.79/3.6 nA
before and 8.99/2.9 nA after injection; n/5, P/0.35,
paired t-test; see Fig. 4. Thus, although the estimated
concentration of brain extracellular O2 is relatively low
at approximately 50 mM (Nair et al., 1987; Murr et al.,
1994), significant increases in its concentration did not
affect the glucose current, supporting the O2 interference
analysis presented in Section 3.2.
A more critical test of the reliability of the Pt/PPD/
GOx sensors to monitor glucose in the presence of
fluctuating pO2 is the effect on the glucose signal of
decreasing ECF pO2. Anaesthetic doses of Ketamine
have been shown recently to cause biphasic changes in
brain ECF pO2 (Lowry and Fillenz, 2001), and so we
used this drug to investigate further the O2 interference
question. Ketamine (200 mg/kg, i.p., see Fig. 5) caused a
decrease in the initial phase of 329/9 mM (n/7, PB/
0.02) in striatal O2 20 min after the injection. At that
time, there was no significant change in the biosensor
signal: 10.69/2.7 nA before and 10.69/2.8 nA 20 min
after injection (n/6, P/0.99, paired t-test). There-
after, the glucose and O2 signals changed in opposite
directions (Fig. 5), reflecting physiological phenomena
and demonstrating further the independence of the
glucose signal from oxygen interference. These findings
suggest that even large decreases in pO2 (/60% based
on present estimates of average pO2 values and post-
implant calibration data) do not affect the ability of Pt/
PPD/GOx electrodes to monitor glucose reliably in
brain ECF in vivo.
4. Conclusions
The in vitro and in vivo studies on the O2 dependence
of Pt/PPD/GOx sensors reported here are internally
consistent and indicate that these biosensors can be used
reliably in brain ECF to monitor glucose even when
there are large fluctuations in pO2. The main factor
enabling this functionality is the relatively low concen-
tration of glucose in brain ECF compared with other
tissues, such as blood and subcutaneous fat where the
levels of glucose could prevent its reliable quantification
using these devices. It remains to be seen whether the O2
insensitivity of Pt/PPD/GOx electrodes in the brain
extends to lower (ischemic) levels of pO2, and to
Fig. 4. The effect of systemic administration of the carbonic anhydrase
inhibitor (Diamox, 50 mg/kg, i.p.) on the O2 and glucose signals
monitored simultaneously in vivo in rat brain (striatum). The O2
current (black) was recorded using DPA with a CPE in the left
striatum while glucose (grey) was detected using amperometry at/700
mV with a Pt/PPD/GOx electrode in the right striatum.
Fig. 5. The effect of systemic administration of an anaesthetic dose of Ketamine (200 mg/kg, i.p. at the arrow) on the O2 and glucose signals
monitored simultaneously in vivo in rat brain. The O2 current (black) was recorded using DPA with a CPE in the left striatum while glucose (grey)
was detected using amperometry at /700 mV with a Pt/PPD/GOx electrode in the right striatum.
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electrodes incorporating other enzymes, such as gluta-
mate and lactate oxidases.
Acknowledgements
We thank Enterprise Ireland for grants under the
Basic Research Grants Scheme (SC/98/450 and SC/99/
149), and the Health Research Board (EQN 12/2000),
U.C.D. and N.U.I., Maynooth for financial support.
J.P.L. gratefully acknowledges the European Commis-
sion for a research training fellowship under the Human
Capital and Mobility programme (Grant No. ERB
CHB ICT94 1353).
References
Bartlett PN, Birkin PR. A microelectrochemical enzyme transistor
responsive to glucose. Anal Chem 1994;66:1552/9.
Bartlett PN, Whitaker RG. Electrochemical immobilization of en-
zymes. Part II. Glucose oxidase immobilized in poly-N -methylpyr-
role. J Electroanal Chem 1987;224:37/48.
Bourdillon C, Thomas V, Thomas D. Electrochemical study of D-
glucose oxidase autoinactivation. Enzyme Microb Technol
1982;4:175/80.
Braguglia CM. Biosensors: an outline of general principles and
application. Chem Biochem Eng Q 1998;12:183/90.
Clark LC, Jr., Lyons C. Electrode systems for continuous monitoring
in cardiovascular surgery. Ann NY Acad Sci 1962;102:29/45.
Clark LC, Jr., Lyons C. Studies of a glassy carbon electrode for brain
polarography with observations on the effect of carbonic anhy-
drase inhibition. Ala J Med Sci 1965;2:353/9.
Di Gleria K, Hill HAO, McNeil CJ, Green MJ. Homogeneous
ferrocene-mediated amperometric immunoassay. Anal Chem
1986;58:1203/5.
Dixon BM, Lowry JP, O’Neill RD. Oxygen dependence of an enzyme/
polymer biosensor designed for brain glucose detection in vivo. In:
O’Connor WT, Lowry JP, O’Connor JJ, O’Neill RD, editors.
Monitoring molecules in neuroscience. Dublin: University College
Dublin, 2001:53/4.
Eyre JA, Stuart AG, Forsyth RJ, Heaviside D, Bartlett K. Glucose
export from the brain in man: evidence for a role for astrocytic
glycogen as a reservoir of glucose for neural metabolism. Brain Res
1994;635:349/52.
Fray AE, Boutelle M, Fillenz M. Extracellular glucose turnover in the
striatum of unanaesthetized rats measured by quantitative micro-
dialysis. J Physiol (London) 1997;504:721/6.
Gao ZQ, Ivaska A, Li P, Lui KZ, Yang JJ. Electrocatalysis and flow-
injection analysis of hydrogen peroxide at a chemically modified
electrode. Anal Chim Acta 1992;259:211/8.
Hofer RE, Lanier WL. The effects of insulin infusion on plasma and
brain glucose in hyperglycemic diabetic rats: a comparison with
placebo-treated diabetic and nondiabetic rats. Anesthesiology
1991;75:673/8.
Kane DA, O’Neill RD. Major differences in the behaviour of carbon
paste and carbon fibre electrodes in a protein-lipid matrix:
implications for voltammetry in vivo. Analyst 1998;123:2899/903.
Karube I, Nomura Y. Enzyme sensors for environmental analysis. J
Mol Catal B / Enz 2000;10:177/81.
Liang LF, Li YT, Yang VC. Biomedical application of immobilized
enzymes. J Pharm Sci 2000;89:979/90.
Lowry JP, Boutelle MG, Fillenz M. Measurement of brain tissue
oxygen at a carbon paste electrode can serve as an index of
increases in regional cerebral blood flow. J Neurosci Methods
1997;71:177/82.
Lowry JP, Boutelle MG, O’Neill RD, Fillenz M. Characterization of
carbon paste electrodes in vitro for simultaneous amperometric
measurement of changes in oxygen and ascorbic acid concentra-
tions in vivo. Analyst 1996;121:761/6.
Lowry JP, Fillenz M. Evidence for uncoupling of oxygen and glucose
utilization during neuronal activation in rat striatum. J Physiol
(London) 1997;498:497/501.
Lowry JP, Fillenz M. Real-time monitoring of brain energy metabo-
lism in vivo using microelectrochemical sensors: the effects of
anesthesia. Bioelectrochemistry 2001;54:39/47.
Lowry JP, McAteer K, El Atrash SS, Duff A, O’Neill RD.
Characterization of glucose oxidase-modified poly(phenylenedia-
mine)-coated electrodes in vitro and in vivo: homogeneous inter-
ference by ascorbic acid in hydrogen peroxide detection. Anal
Chem 1994a;66:1754/61.
Lowry JP, McAteer K, El Atrash SS, O’Neill RD. Efficient glucose
detection in anaerobic solutions using an enzyme-modified elec-
trode designed to detect H2O2: implications for biomedical
applications. J Chem Soc Chem Commun 1994b;21:2483/4.
Lowry JP, Miele M, O’Neill RD, Boutelle MG, Fillenz M. An
amperometric glucose-oxidase/poly(o -phenylenediamine) biosen-
sor for monitoring brain extracellular glucose: in vivo character-
isation in the striatum of freely-moving rats. J Neurosci Methods
1998b;79:65/74.
Lowry JP, O’Neill RD, Boutelle MG, Fillenz M. Continuous
monitoring of extracellular glucose concentrations in the striatum
of freely moving rats with an implanted glucose biosensor. J
Neurochem 1998a;70:391/6.
Lucisano JY, Gough DA. Transient response of the two-dimensional
glucose sensor. Anal Chem 1988;60:1272/81.
Magner E. Trends in electrochemical biosensors. Analyst
1998;123:1967/70.
Malitesta C, Palmisano F, Torsi L, Zambonin PG. Glucose fast-
response amperometric sensor based on glucose oxidase immobi-
lized in an electropolymerized poly(o -phenylenediamine) film. Anal
Chem 1990;62:2735/40.
Martens N, Hall EAH. Model for an immobilized oxidase enzyme
electrode in the presence of two oxidants. Anal Chem
1994;66:2763/70.
McNay EC, McCarty RC, Gold PE. Fluctuations in brain glucose
concentration during behavioral testing: dissociations between
brain areas and between brain and blood. Neurobiol Learn
Memory 2001;75:325/37.
Murr R, Berger S, Schuerer L, Peter K, Baethmann A. A novel,
remote-controlled suspension device for brain tissue PO2 measure-
ments with multiwire surface electrodes. Pflugers Arch
1994;426:348/50.
Nair PK, Buerk DG, Halsey JH, Jr.. Comparison of oxygen
metabolism and tissue pO2 in cortex and hippocampus. Stroke
1987;18:616/22.
O’Neill RD. Sensor-tissue interactions in neurochemical analysis with
carbon paste electrodes in vivo. Analyst 1993;118:433/8.
O’Neill RD, Lowry JP. Voltammetry in vivo for chemical analysis of
the living brain. In: Meyers R, editor. Encyclopedia of analytical
chemistry. Chichester: Wiley, 2000:676/709.
O’Neill RD, Lowry JP, Mas M. Monitoring brain chemistry in vivo:
voltammetric techniques, sensors and behavioral applications. Crit
Rev Neurobiol 1998;12:69/127.
Pishko MV, Michael AC, Heller A. Amperometric glucose microelec-
trodes prepared through immobilization of glucose oxidase in
redox hydrogels. Anal Chem 1991;63:2268/72.
B.M. Dixon et al. / Journal of Neuroscience Methods 119 (2002) 135/142 141
Razumas V, Kulys J, Knichel M, Wiemhofer HD, Gopel W.
Monoalkylferrocene-mediated amperometric enzyme electrodes
for glucose determination. Electroanalysis 1993;5:399/404.
Reynolds ER, Yacynych AM. Platinized carbon ultramicroelectrodes
as glucose biosensors. Electroanalysis 1993;5:405/11.
Sakamoto N. Effect of enzyme concentration on the dynamic behavior
of a membrane-bound enzyme system. J Membr Sci 1992;70:237/
47.
Sasso SV, Pierce RJ, Walla R, Yacynych AM. Electropolymerized 1,2-
diaminobenzene as a means to prevent interferences and fouling
and to stabilize immobilized enzyme in electrochemical biosensors.
Anal Chem 1990;62:1111/7.
Scheller F, Kirstein D, Schubert F, Pfeiffer D, McNeil C. Enzymes in
electrochemical biosensors. Russ J Electrochem 1993;29:1334/8.
Siesjo BK. Brain energy metabolism. Chichester: Wiley, 1978.
Updike SJ, Hicks GP. The enzyme electrode. Nature (London)
1967;214:986/8.
Vreeke M, Maidan R, Heller A. Hydrogen peroxide and beta-
nicotinamide adenine dinucleotide sensing amperometric electrodes
based on electrical connection of horseradish peroxidase redox
centers to electrodes through a 3-dimensional electron relaying
polymer network. Anal Chem 1992;64:3084/90.
Wang J. Electroanalysis and biosensors. Anal Chem 1993;65:R450/3.
Wang J. Glucose biosensors: 40 years of advances and challenges.
Electroanalysis 2001;13:983/8.
Wang J, Liu J, Chen L, Lu F. Highly selective membrane-free,
mediator-free glucose biosensor. Anal Chem 1994;66:3600/3.
Wang J, Lu F. Oxygen-rich oxidase enzyme electrodes for operation in
oxygen-free solutions. J Am Chem Soc 1998;120:1048/50.
Wang J, Rivas G, Chicharro M. Iridium-dispersed carbon paste
enzyme electrodes. Electroanalysis 1996;8:434/7.
Wilke D, Muller H. Preparation and analytical testing of mediator
containing photolithographically patterned enzyme membrane
electrodes. Fresenius J Anal Chem 1994;349:661/5.
Zhang S, Wright G, Yang Y. Materials and techniques for electro-
chemical biosensor design and construction. Biosensors Bioelec-
tron 2000;15:273/82.
Zhang YN, Wilson GS. In vitro and in vivo evaluation of oxygen
effects on a glucose oxidase based implantable glucose sensor. Anal
Chim Acta 1993;281:513/20.
B.M. Dixon et al. / Journal of Neuroscience Methods 119 (2002) 135/142142
